Keynote speakers

Professor Riitta Seppänen Kaijansinkko


Professor of  Translational Research on Oral and Maxillofacial Sciences,

Department of Oral and Maxillofacial Sciences,Clinicum,

University of Helsinki


Professor Riitta received her DDS in 1986 and MD, PhD in 1996 from University of Helsinki, Finland. She completed her OMFS residency in 1999 and her European Board of Oral and Maxillofacial Surgery in 2002. She received Special Competence in Medical and Dental Education in 2010. She is currently working as Professor of Translational Research on Oral and Maxillofacial Sciences and as Chief Physician in Helsinki University and University Hospital.  Her current interests are tissue engineering, including recently initiated exosome research. She has received several honors, including the Apollonia Prize and Arje Scheinin medal. In 2012, she was awarded Dr. Tech (h.c.) from Tampere University of Technology and Honorary Professorship from University of Hong Kong.


Professor Dietmar W. Hutmacher


Professor and Chair in Regenerative Medicine,

Queensland University of Technology


Prof Hutmacher is a Research Capacity Building Professor, Director of the Centre of Regenerative Medicine at the Queensland University of Technology (QUT) and Director of the ARC Training Centre for Additive Biomanufacturing in Australia. Over the last decade, he has gained a worldwide recognition in the field of biomaterials, tissue engineering & regenerative medicine. His preeminent international standing and impact in the field are demonstrated by his publication record (>260 journal articles, edited 14 books, 45 book chapters and >450 conference abstracts) and citation record (>18.600 citations, h-index of 67). His outstanding research career, former industry experience and MBA have equipped him with the scientific expertise, leadership profile and management experience to undertake cutting edge basic and translational research which has led to significant improvements in our fundamental understandings, but more importantly from a far more wide reaching perspective to innovations that has improved the quality of life for many patients. More than 400 patients have been treated with the FDA-approved bone engineering scaffolds developed by Prof Hutmacher’s Singapore-based interdisciplinary research group.

Prof Hutmacher's success in both academic and pivotal commercialization outcomes, has been achieved through a concerted and integrated leadership effort for interdisciplinary collaborations. He has gained a thorough understanding of the status in the STEM and biomedical field, and a clear vision of the needs for the 21st century from both an academic and educational point of view.  He has won numerous awards and has been lead CI, Co-CI or collaborator in grants totalling more than AUD$50 million over the past 15 years.

Symposium speakers

Professor McGrouther Duncan Angus


Senior Consultant,

Department of Hand Surgery,

Singapore General Hopsital 


Prof McGrouther graduated from the University of Glasgow in Medicine in 1969, the University of Strathclyde in Bioengineering 1975, and gained his MD (honours) Glasgow 1988. In 1989 he was appointed to the first established UK chair in Plastic and Reconstructive Surgery at University College London (UCL). Professor McGrouther moved to the University of Manchester in 2001 to focus his research on wound healing, tissue repair and tissue engineering, with laboratory programmes in tendon repair, peripheral nerve repair and scar formation. Since 2014 he has been Senior Consultant Hand Surgeon at Singapore General Hospital and Adjunct Professor at Duke-NUS Medical School.


For his research he was awarded a Wolfson Royal Society merit award, and has been elected a Fellow of the Academy of Medical Sciences, UK. Elected to the Royal College  of Surgeons of England  Council (2010-2014), Prof  McGrouther chaired numerous committees concerned with Surgical education and standards. He has delivered many public lectures (on 3 occasions attended by HRH Prince Phillip) communicating the surgeon’s art to a wider audience.

Professor Karl Tryggvason


Professor,Cardiovascular and Metabolic Disorders Programme

Duke-NUS Medical School

Karl Tryggvason, MD, PhD, is Tanoto Professor of Diabetes Research at Duke-NUS and Senior Professor of Medical Chemistry at the Karolinska Institute in Stockholm, and a specialist in Clinical Chemistry. His research concerns the molecular nature, biology and diseases of basement membranes (BM), a special compartment of the extracellular matrix (ECM). His group has cloned almost all human BM proteins and clarified the genetic causes of many BM-associated diseases, such as Alport syndrome, congenital nephrotic syndrome, junctional epidermolysis bullosa and congenital muscular dystrophy, as well as studied matrix metalloproteinases, including the discovery and crystal structure of MMP-2. Tryggvason’s main research areas at Duke-NUS involve an extensive approach to the characterization of ECM proteins called laminins that have important roles in cell-matrix interactions during cell differentiation and maintenance of phenotypes and his laboratory has cloned most of them and produced as recombinant proteins. Tryggvason has published over 380 research articles. He is a member of the Finnish Academy of Sciences and the Swedish Royal Academy of Sciences, and has served for 18 years as a member of the Nobel Assembly and Committee at the Karolinska Institute. He has received several international awards like the American Society of Nephrology Homer Smith Award and the Louis-Jeantet and Anders Jahre Prizes in Medicine. Tryggvason is co-founder of BioLamina AB, Stockholm, that produces laminins for cell biology and cell therapy purposes.

Professor David Becker


Professor in Tissue Repair and Regeneration,

Lee Kong Chian School of Medicine,

Nanyang Technological University

Prof David Becker obtained his BSc in Biology in 1985 and his PhD in 1988 at University College London. In 1994 he was awarded a Royal Society Research Fellowship and in 2008 was made full Professor at UCL. In 2013 he joined the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.  He has published over 125 research articles and book chapters, with a Publication H-Index of 36 and acts as a reviewer for many international journals and international grant funding agencies.  For his translational research he has more than thirty worldwide patents pending and granted. In 2003 he won the Medical Futures Nomura award for the Best Biotech Start-Up Innovation.  In 2006 he was a founding scientist of CoDaTherapeutics Inc, which has raised over $70M to develop Nexagon, a drug, which drives the healing of chronic wounds.  Nexagon has shown efficacy in phase 2B clinical trials on venous leg ulcers and is now being trialed on diabetic ulcers.

Professor James Hui Hoi Po


Head & Senior Consultant

Division of Paediatric Orthopaedics

Director of Cartilage Repair Program

Department of Orthopaedic Surgery

National University Health System


Prof James Hui received his MBBS degree from National University of Singapore in 1990.  He received his FRCS (Royal College of Surgeons, (Edinburgh UK)) in 1994, FAMS (Academy of Medicine, Singapore) in 1999 and Doctor of Medicine (National University of Singapore) in 2008.  Dr Hui is currently a Professor at the Department of Orthopaedic Surgery, National University of Singapore.  He is heading Division of Paediatric Orthopaedics and is Director of Clinical Services for Department of Orthopaedic Surgery, National University Hospital.  He was also appointed as Director for Tissue Engineering and Cell Therapy Laboratory, National University Health System, Singapore and is a Group Leader for Cartilage Division of National University of Singapore, Tissue Engineering Programme (NUSTEP).  He is also currently the vice-president of Asian Cartilage Repair Society.


Dr Siti Radhziah Binte Sudirman


Associate Consultant,

Department of Otolaryngology,

Singapore General Hospital

Dr Siti Radhziah is an Associate Consultant at the Department of Otolaryngology, Singapore General Hospital. She graduated with MBBS from the National University of Singapore in 2007. She obtained her MRCS (Ireland) in 2010 and MMed (Otolaryngology) in 2012. She has interests in head and neck oncology and voice rehabilitation.

Associate Professor Chew Sing Yian


Associate Chair (Research),

School of Chemical and Biomedical Engineering,

Nanyang Technological University; and


Associate Professor,

Lee Kong Chian School of Medicine


Assoc Prof Chew Sing Yian is an Associate Professor at the Lee Kong Chian School of Medicine (LKCMedicine) and the School of Chemical & Biomedical Engineering (SCBE), Nanyang Technological University (NTU), Singapore. Assoc Prof Chew obtained her PhD at Johns Hopkins University in 2006, under the sponsorship of the NTU Overseas Scholarship. Thereafter, she joined SCBE as Assistant Professor later in the same year. In 2012, Assoc Prof Chew received her tenure and was promoted to Associate Professor in SCBE. In March 2014, Assoc Prof Chew received joint appointment with LKCMedicine. Starting July 2014, she serves as Associate Chair of Research in SCBE.

Assoc Prof Chew is known for her contributions to the field of regenerative medicine and stem cell engineering. Her research interests lie in understanding the combined effects of nanotopography and biochemical signalling in directing cell fate. Specifically, her lab engineers nanofiber platforms for long-term delivery of biochemicals. Currently, Assoc Prof Chew’s work focuses on scaffold-mediated delivery of small non-coding RNAs for long-term gene silencing applications. These biofunctional platforms are used for understanding and directing neural tissue regeneration post-traumatic injuries, stem cell fate and host-implant integration.

Since joining NTU, Assoc Prof Chew has continued to embark on scientific learning and exchanges by serving as visiting scholar/professor to INSERM (U698 and U791); University of Paris 13; University of Nantes; Jinan University in Guangzhou, China; and Wyss Institute at Harvard. She also serves as the editorial board member in Drug Delivery and Translational Research, a new official journal of the highly regarded Controlled Release Society. Her professional experience also includes evaluating research grants for local and international funding bodies including the Research Grant Council of Hong Kong.


Assistant Professor Hemant Unadkat


Clinician Scientist,

National Dental Centre of Singapore; and


Assistant Professor,

Duke-NUS Medical School


Dr Hemant’s research is dedicated to understanding and applying basic cell biological principles in particular to the regeneration of craniofacial tissues. His research programme is characterized by a holistic approach to both discovery and application, aiming at combining high throughput technologies, computational modeling and experimental cell biology to streamline the wealth of biological knowledge to real clinical applications. Previously Dr Hemant has been a recepient of European Society for Biomaterials Doctoral Award amongst others. His work has so far led to 4 patent applications and has attracted a funding of > $2.5 M as PI and Co-I.


Assistant Professor Srinivasan Kellathur



Advanced Therapy Products Unit,

Singapore Health Sciences Authority; and


Assistant Professor,

Centre of Regulatory Excellence,

Duke-NUS Medical School


Srinivasan Kellathur is currently the Head of Advanced Therapy Products Unit at the Singapore Health Sciences Authority and Adjunct Assistant Professor at the Centre of Regulatory Excellence, Duke-NUS Medical School. He is involved in the development of policies, guidelines and framework for the regulation of cellular and tissue-based and gene therapeutic products. Srini received his PhD from the National University of Singapore and postdoctoral training from the Johns Hopkins University School of Medicine. He is a member of several advisory committees of the Singapore Ministry of Health on matters related to bio-banking and human biomedical research, APEC Harmonization Centre Advisory Board for Cellular Therapies and Vice-President (Singapore) of the Asian Cellular Therapy Organization.






Copyright © 2013. All rights reserved.